XPH News and Press, SPDR S&P Pharmaceuticals

2024-07-03 22:30:00 ET Summary Closing out the first half of 2024, the S&P 500 Total Return Index (which includes dividend reinvestment) is up an incredible +15.3%. According to Apollo asset management, Nvidia accounted for a record-breaking 34.5% of the total return in the S&...

2024-07-03 09:41:00 ET Summary Global stocks posted healthy gains in the first half of 2024, although second quarter performance moderated from the previous quarter’s breakneck pace. In a trend that has become familiar to equity investors, large-cap market breadth was again...

2024-07-03 08:00:00 ET Summary The economy underneath has been very strong, and that’s really what’s enabled the Fed to actually push out those interest rate cuts. The best performing sector has been technology with all of the AI powering the technology gains. Th...

2024-06-26 21:15:00 ET Summary As global policymakers push forward in their attempts to transition away from fossil fuels, the demand for substitutes in the form of minerals and metals is skyrocketing. The green transition is driving this unprecedented demand for metals and minera...

2024-06-24 13:02:35 ET More on SPDR S&P Pharmaceuticals ETF XPH: A More Balanced Way To Get Exposure To Pharmaceuticals Seeking Alpha’s Quant Rating on SPDR S&P Pharmaceuticals ETF Dividend scorecard for SPDR S&P Pharmaceuticals ETF Read ...

2024-06-08 02:20:00 ET Summary Health care spending now accounts for 17% of the U.S. GDP, and the health care sector can be especially sensitive to policy changes. There are broadly four options for health insurance coverage in the U.S.: employers, medical exchanges, Medicaid, and...

2024-05-27 01:45:30 ET Summary Gilead is sitting at one of the lowest valuations in the Big Pharma sector, with a high and sustainable 4.6% dividend yield available for new buyers. The stock has an enviable track record of rising strongly in price when turmoil hits Wall Street and...

2024-05-23 04:15:00 ET Summary S&P 500 earnings growth of 5% was driven primarily by the mega-cap tech+ stocks. We remain positive on technology and internet stocks but expect the earnings growth chasm between these leaders and the rest to close as two divergent business cycle...

Amphenol Corporation (NYSE: APH) today announced it had completed the acquisition of the Carlisle Interconnect Technologies (CIT) business from Carlisle Companies Incorporated (NYSE: CSL). “The acquisition of CIT enhances Amphenol’s product offerings for highly engineered harsh ...

Amphenol Corporation (NYSE: APH) today announced that its Board of Directors approved a two-for-one stock split to be paid in the form of a stock dividend. Each Amphenol shareholder of record at the close of business on May 31, 2024 will receive one additional share for every share held on the re...